Literature DB >> 17590432

Calcium homeostasis is abnormal in cystic fibrosis airway epithelial cells but is normalized after rescue of F508del-CFTR.

Fabrice Antigny1, Caroline Norez, Frédéric Becq, Clarisse Vandebrouck.   

Abstract

Retention of F508del-CFTR proteins in the endoplasmic reticulum (ER) is dependent upon chaperone proteins, many of which require Ca(2+) for optimal activity. Here, we show in human tracheal gland CF-KM4 cells, that after correction of F508del-CFTR trafficking by miglustat (N-butyldeoxynojirimycin) or low temperature (27 degrees C), the Ca(2+) mobilization is decreased compared to uncorrected cells and becomes identical to the Ca(2+) response observed in non-CF MM39 cells. In CF-KM4 and human nasal epithelial CF15 cells, we also show that inhibiting vesicular trafficking by nocodazole prevents not only the rescue of F508del-CFTR but also the Ca(2+) mobilization decrease. Finally, experiments using the CFTR inhibitor CFTR(inh)-172 showed that the presence but not the channel activity of F508del-CFTR at the plasma membrane is required to decrease the Ca(2+) mobilization in corrected CF cells. These findings show that correction of the abnormal trafficking of F508del-CFTR proteins might have profound consequences on cellular homeostasis such as the control of intracellular Ca(2+) level.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17590432     DOI: 10.1016/j.ceca.2007.05.002

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  26 in total

1.  Abnormal n-6 fatty acid metabolism in cystic fibrosis is caused by activation of AMP-activated protein kinase.

Authors:  Obi C Umunakwe; Adam C Seegmiller
Journal:  J Lipid Res       Date:  2014-05-24       Impact factor: 5.922

Review 2.  Ion channels of the lung and their role in disease pathogenesis.

Authors:  Rafal Bartoszewski; Sadis Matalon; James F Collawn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-10-12       Impact factor: 5.464

Review 3.  The secret life of CFTR as a calcium-activated chloride channel.

Authors:  Arnaud Billet; John W Hanrahan
Journal:  J Physiol       Date:  2013-08-19       Impact factor: 5.182

4.  Inhibition of calpain 1 restores plasma membrane stability to pharmacologically rescued Phe508del-CFTR variant.

Authors:  Ana M Matos; Francisco R Pinto; Patrícia Barros; Margarida D Amaral; Rainer Pepperkok; Paulo Matos
Journal:  J Biol Chem       Date:  2019-07-19       Impact factor: 5.157

5.  Calcium-modulated chloride pathways contribute to chloride flux in murine cystic fibrosis-affected macrophages.

Authors:  Ambika Shenoy; Sascha Kopic; Michael Murek; Christina Caputo; John P Geibel; Marie E Egan
Journal:  Pediatr Res       Date:  2011-11       Impact factor: 3.756

6.  Enhanced Ca2+ entry due to Orai1 plasma membrane insertion increases IL-8 secretion by cystic fibrosis airways.

Authors:  Haouaria Balghi; Renaud Robert; Benjamin Rappaz; Xuexin Zhang; Adeline Wohlhuter-Haddad; Alexandra Evagelidis; Yishan Luo; Julie Goepp; Pasquale Ferraro; Philippe Roméo; Mohamed Trebak; Paul W Wiseman; David Y Thomas; John W Hanrahan
Journal:  FASEB J       Date:  2011-08-26       Impact factor: 5.191

7.  The impact of Cystic Fibrosis Transmembrane Regulator Disruption on cardiac function and stress response.

Authors:  Kai Jiang; Sen Jiao; Megan Vitko; Rebecca Darrah; Chris A Flask; Craig A Hodges; Xin Yu
Journal:  J Cyst Fibros       Date:  2015-06-25       Impact factor: 5.482

8.  Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.

Authors:  Thierry Ntimbane; Blandine Comte; Geneviève Mailhot; Yves Berthiaume; Vincent Poitout; Marc Prentki; Rémi Rabasa-Lhoret; Emile Levy
Journal:  Clin Biochem Rev       Date:  2009-11

Review 9.  What's new in cystic fibrosis? From treating symptoms to correction of the basic defect.

Authors:  Marijke Proesmans; François Vermeulen; Kris De Boeck
Journal:  Eur J Pediatr       Date:  2008-04-04       Impact factor: 3.183

Review 10.  Dysregulated Chemokine Signaling in Cystic Fibrosis Lung Disease: A Potential Therapeutic Target.

Authors:  Xiaoqing Guan; Yuning Hou; Fei Sun; Zhe Yang; Chunying Li
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.